
Investigators take first look at a second drug to combat sickle cell disease by turning up fetal hemoglobin
May 11, 2023
The drugs are called HDAC inhibitors, and the investigators have early evidence one can reactivate after birth the gene that produces fetal hemoglobin, which cannot sickle.